更正：评估新辅助卡雷珠单抗和阿帕替尼治疗复发性高级别胶质瘤患者安全性和有效性的临床试验的初步报告：一项前瞻性II期单臂研究

{"title":"更正：评估新辅助卡雷珠单抗和阿帕替尼治疗复发性高级别胶质瘤患者安全性和有效性的临床试验的初步报告：一项前瞻性II期单臂研究","authors":"","doi":"10.4103/glioma.glioma_19_22","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12731,"journal":{"name":"Glioma","volume":"5 1","pages":"110 - 111"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study\",\"authors\":\"\",\"doi\":\"10.4103/glioma.glioma_19_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12731,\"journal\":{\"name\":\"Glioma\",\"volume\":\"5 1\",\"pages\":\"110 - 111\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Glioma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/glioma.glioma_19_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glioma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/glioma.glioma_19_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}